Lucy Sinclair

Dr. Lucy Sinclair is a Research Fellow in Biomedical Engineering at the University of Strathclyde, United Kingdom. Her primary research focuses on antimicrobial applications of 405-nm light technology for bacterial and viral decontamination, with particular emphasis on healthcare settings and pandemic response applications.

Dr. Sinclair's research interests center on Antimicrobial Photodynamic Therapy, Biomedical Engineering applications of visible light, and Infectious Disease Control. Her work demonstrates how low-irradiance 405-nm light systems can effectively inactivate bacterial pathogens including Staphylococcus aureus and ESKAPE pathogens, as well as viral surrogates for SARS-CoV-2. Her research uniquely addresses both the antimicrobial efficacy and energy efficiency aspects of these systems, making them potentially viable for widespread clinical implementation.

Analysis of Dr. Sinclair's publication record from 2019-2024 reveals a consistent focus on optimizing 405-nm light systems for various decontamination applications. Her work spans surface decontamination, air purification, and even blood plasma treatment, demonstrating the versatility of this antimicrobial approach. The research shows particular attention to real-world implementation challenges including energy efficiency, material surface properties, and pathogen load considerations.

Dr. Sinclair has received at least one research prize for her contributions to the field of antimicrobial photodynamic therapy, though specific details of the award are not provided in the available materials.

Her collaborative research involves significant work with colleagues including MacGregor, Maclean, and Anderson, suggesting active participation in multidisciplinary research teams focused on developing practical antimicrobial technologies for healthcare settings.